1 | alternative | 15,163 |
2 | adaptogen | 18 |
3 | alterative | 13 |
4 | time-delay | 9 |
5 | alternative/complementary | 6 |
6 | bpmp | 6 |
7 | omen | 6 |
8 | elgp | 4 |
9 | antimicrobical | 3 |
10 | apob-based | 3 |
11 | counterplans | 3 |
12 | imatinib-based | 3 |
13 | primulin-staining | 3 |
14 | sociobiological | 3 |
15 | 125i-hdl3 | 2 |
16 | ace-i-arb-combination | 2 |
17 | agenda-based-regulation | 2 |
18 | aldol-type | 2 |
19 | antihepcidin | 2 |
20 | auxiliary-variable | 2 |
21 | azt-containing | 2 |
22 | bioagent | 2 |
23 | easy-to-disseminate | 2 |
24 | endo-cleavage | 2 |
25 | enrichment-window | 2 |
26 | er-independent | 2 |
27 | etravirine-containing | 2 |
28 | grievances | 2 |
29 | injection-based | 2 |
30 | isonatric | 2 |
31 | neocartilage | 2 |
32 | nonreperfusion | 2 |
33 | open-entry | 2 |
34 | para-clinical | 2 |
35 | spi-mepei | 2 |
36 | stat3-targeting | 2 |
37 | ultrasound-first | 2 |
38 | un-restricted | 2 |
39 | x-omics | 2 |
40 | 5-endo-trig | 1 |
41 | accuracy-improved | 1 |
42 | acw-treatment | 1 |
43 | addition-rearrangement | 1 |
44 | advance-and-scan | 1 |
45 | aeds-one | 1 |
46 | agar-plate-dilution | 1 |
47 | agonist-type | 1 |
48 | akt-resistant | 1 |
49 | alisporivir-containing | 1 |
50 | ammonia-evaporation-induced | 1 |
51 | ampkα2-dependent | 1 |
52 | amt-platinum | 1 |
53 | animal-screening | 1 |
54 | anova-based | 1 |
55 | anthracyclin-based | 1 |
56 | anthroposophy | 1 |
57 | anti-chikv | 1 |
58 | anti-cramp | 1 |
59 | anti-heart-failure | 1 |
60 | anti-telomerase | 1 |
61 | array-designed | 1 |
62 | atv/r-based | 1 |
63 | aural/oral | 1 |
64 | azathioprine-based | 1 |
65 | azithromycin-based | 1 |
66 | aβ-lowering | 1 |
67 | camp-activating | 1 |
68 | catalyst/co-catalyst | 1 |
69 | cell/pharmacological | 1 |
70 | cf-based | 1 |
71 | cu/rh-catalyzed | 1 |
72 | cyanogel-derived | 1 |
73 | dose-measuring | 1 |
74 | double-filtering | 1 |
75 | e7-expressing | 1 |
76 | ecient | 1 |
77 | eeg-dependent | 1 |
78 | endosome-recycling | 1 |
79 | epha4-lyn | 1 |
80 | epidural-only | 1 |
81 | epob-treated | 1 |
82 | esti-mated | 1 |
83 | everolimus-csa-steroid | 1 |
84 | falicov–kimball | 1 |
85 | flt-based | 1 |
86 | heat-avoiding | 1 |
87 | hplc-pad-ms | 1 |
88 | hplc/dad/esi-ms/ms | 1 |
89 | hplc/dad/esi/ms | 1 |
90 | ifnγ-independent | 1 |
91 | immundiagnostic | 1 |
92 | immunocap-based | 1 |
93 | immunofocus-staining | 1 |
94 | in-rich | 1 |
95 | indinavir-dual | 1 |
96 | induced-fit-type | 1 |
97 | interaction/exfoliation | 1 |
98 | ionic-to-electronic | 1 |
99 | iridium-catalyzed | 1 |
100 | lcms-sim | 1 |
101 | liber8 | 1 |
102 | m-b | 1 |
103 | mda-tba/hplc | 1 |
104 | mental-simulation | 1 |
105 | nf-κb-independent | 1 |
106 | no/cgmp/pkg-dependent | 1 |
107 | nonparticulant | 1 |
108 | oft-used | 1 |
109 | oh-directed | 1 |
110 | open-care | 1 |
111 | open-suction | 1 |
112 | orally-administrable | 1 |
113 | orientation-determination | 1 |
114 | par-2-directed | 1 |
115 | pre-aus | 1 |
116 | psycho-rehabilitation | 1 |
117 | pyrene-assisted | 1 |
118 | revascularization/thrombotic | 1 |
119 | sample-preparation | 1 |
120 | self-medicative | 1 |
121 | sof-containing | 1 |
122 | tdf+ftc+zdv | 1 |
123 | thumbs-up | 1 |
124 | unresourceful | 1 |
125 | wet-chemical | 1 |
126 | α-neurexin-specific | 1 |
1 | 125i-hdl3 | 2 |
2 | 5-endo-trig | 1 |
3 | accuracy-improved | 1 |
4 | ace-i-arb-combination | 2 |
5 | acw-treatment | 1 |
6 | adaptogen | 18 |
7 | addition-rearrangement | 1 |
8 | advance-and-scan | 1 |
9 | aeds-one | 1 |
10 | agar-plate-dilution | 1 |
11 | agenda-based-regulation | 2 |
12 | agonist-type | 1 |
13 | akt-resistant | 1 |
14 | aldol-type | 2 |
15 | alisporivir-containing | 1 |
16 | alterative | 13 |
17 | alternative | 15,163 |
18 | alternative/complementary | 6 |
19 | ammonia-evaporation-induced | 1 |
20 | ampkα2-dependent | 1 |
21 | amt-platinum | 1 |
22 | animal-screening | 1 |
23 | anova-based | 1 |
24 | anthracyclin-based | 1 |
25 | anthroposophy | 1 |
26 | anti-chikv | 1 |
27 | anti-cramp | 1 |
28 | anti-heart-failure | 1 |
29 | anti-telomerase | 1 |
30 | antihepcidin | 2 |
31 | antimicrobical | 3 |
32 | apob-based | 3 |
33 | array-designed | 1 |
34 | atv/r-based | 1 |
35 | aural/oral | 1 |
36 | auxiliary-variable | 2 |
37 | azathioprine-based | 1 |
38 | azithromycin-based | 1 |
39 | azt-containing | 2 |
40 | aβ-lowering | 1 |
41 | bioagent | 2 |
42 | bpmp | 6 |
43 | camp-activating | 1 |
44 | catalyst/co-catalyst | 1 |
45 | cell/pharmacological | 1 |
46 | cf-based | 1 |
47 | counterplans | 3 |
48 | cu/rh-catalyzed | 1 |
49 | cyanogel-derived | 1 |
50 | dose-measuring | 1 |
51 | double-filtering | 1 |
52 | e7-expressing | 1 |
53 | easy-to-disseminate | 2 |
54 | ecient | 1 |
55 | eeg-dependent | 1 |
56 | elgp | 4 |
57 | endo-cleavage | 2 |
58 | endosome-recycling | 1 |
59 | enrichment-window | 2 |
60 | epha4-lyn | 1 |
61 | epidural-only | 1 |
62 | epob-treated | 1 |
63 | er-independent | 2 |
64 | esti-mated | 1 |
65 | etravirine-containing | 2 |
66 | everolimus-csa-steroid | 1 |
67 | falicov–kimball | 1 |
68 | flt-based | 1 |
69 | grievances | 2 |
70 | heat-avoiding | 1 |
71 | hplc-pad-ms | 1 |
72 | hplc/dad/esi-ms/ms | 1 |
73 | hplc/dad/esi/ms | 1 |
74 | ifnγ-independent | 1 |
75 | imatinib-based | 3 |
76 | immundiagnostic | 1 |
77 | immunocap-based | 1 |
78 | immunofocus-staining | 1 |
79 | in-rich | 1 |
80 | indinavir-dual | 1 |
81 | induced-fit-type | 1 |
82 | injection-based | 2 |
83 | interaction/exfoliation | 1 |
84 | ionic-to-electronic | 1 |
85 | iridium-catalyzed | 1 |
86 | isonatric | 2 |
87 | lcms-sim | 1 |
88 | liber8 | 1 |
89 | m-b | 1 |
90 | mda-tba/hplc | 1 |
91 | mental-simulation | 1 |
92 | neocartilage | 2 |
93 | nf-κb-independent | 1 |
94 | no/cgmp/pkg-dependent | 1 |
95 | nonparticulant | 1 |
96 | nonreperfusion | 2 |
97 | oft-used | 1 |
98 | oh-directed | 1 |
99 | omen | 6 |
100 | open-care | 1 |
101 | open-entry | 2 |
102 | open-suction | 1 |
103 | orally-administrable | 1 |
104 | orientation-determination | 1 |
105 | par-2-directed | 1 |
106 | para-clinical | 2 |
107 | pre-aus | 1 |
108 | primulin-staining | 3 |
109 | psycho-rehabilitation | 1 |
110 | pyrene-assisted | 1 |
111 | revascularization/thrombotic | 1 |
112 | sample-preparation | 1 |
113 | self-medicative | 1 |
114 | sociobiological | 3 |
115 | sof-containing | 1 |
116 | spi-mepei | 2 |
117 | stat3-targeting | 2 |
118 | tdf+ftc+zdv | 1 |
119 | thumbs-up | 1 |
120 | time-delay | 9 |
121 | ultrasound-first | 2 |
122 | un-restricted | 2 |
123 | unresourceful | 1 |
124 | wet-chemical | 1 |
125 | x-omics | 2 |
126 | α-neurexin-specific | 1 |
1 | 125i-hdl3 | 2 |
2 | liber8 | 1 |
3 | m-b | 1 |
4 | α-neurexin-specific | 1 |
5 | ionic-to-electronic | 1 |
6 | isonatric | 2 |
7 | revascularization/thrombotic | 1 |
8 | immundiagnostic | 1 |
9 | mda-tba/hplc | 1 |
10 | ammonia-evaporation-induced | 1 |
11 | array-designed | 1 |
12 | anova-based | 1 |
13 | imatinib-based | 3 |
14 | apob-based | 3 |
15 | azathioprine-based | 1 |
16 | cf-based | 1 |
17 | azithromycin-based | 1 |
18 | anthracyclin-based | 1 |
19 | injection-based | 2 |
20 | immunocap-based | 1 |
21 | atv/r-based | 1 |
22 | flt-based | 1 |
23 | oft-used | 1 |
24 | epob-treated | 1 |
25 | esti-mated | 1 |
26 | par-2-directed | 1 |
27 | oh-directed | 1 |
28 | un-restricted | 2 |
29 | pyrene-assisted | 1 |
30 | cyanogel-derived | 1 |
31 | accuracy-improved | 1 |
32 | cu/rh-catalyzed | 1 |
33 | iridium-catalyzed | 1 |
34 | everolimus-csa-steroid | 1 |
35 | neocartilage | 2 |
36 | endo-cleavage | 2 |
37 | auxiliary-variable | 2 |
38 | orally-administrable | 1 |
39 | aeds-one | 1 |
40 | aldol-type | 2 |
41 | induced-fit-type | 1 |
42 | agonist-type | 1 |
43 | open-care | 1 |
44 | anti-heart-failure | 1 |
45 | anti-telomerase | 1 |
46 | easy-to-disseminate | 2 |
47 | self-medicative | 1 |
48 | alternative | 15,163 |
49 | alterative | 13 |
50 | 5-endo-trig | 1 |
51 | heat-avoiding | 1 |
52 | endosome-recycling | 1 |
53 | animal-screening | 1 |
54 | etravirine-containing | 2 |
55 | sof-containing | 1 |
56 | alisporivir-containing | 1 |
57 | azt-containing | 2 |
58 | primulin-staining | 3 |
59 | immunofocus-staining | 1 |
60 | double-filtering | 1 |
61 | aβ-lowering | 1 |
62 | dose-measuring | 1 |
63 | e7-expressing | 1 |
64 | camp-activating | 1 |
65 | stat3-targeting | 2 |
66 | in-rich | 1 |
67 | spi-mepei | 2 |
68 | antimicrobical | 3 |
69 | cell/pharmacological | 1 |
70 | sociobiological | 3 |
71 | wet-chemical | 1 |
72 | para-clinical | 2 |
73 | aural/oral | 1 |
74 | indinavir-dual | 1 |
75 | falicov–kimball | 1 |
76 | unresourceful | 1 |
77 | lcms-sim | 1 |
78 | amt-platinum | 1 |
79 | advance-and-scan | 1 |
80 | adaptogen | 18 |
81 | omen | 6 |
82 | antihepcidin | 2 |
83 | nonreperfusion | 2 |
84 | interaction/exfoliation | 1 |
85 | agenda-based-regulation | 2 |
86 | mental-simulation | 1 |
87 | ace-i-arb-combination | 2 |
88 | orientation-determination | 1 |
89 | sample-preparation | 1 |
90 | psycho-rehabilitation | 1 |
91 | open-suction | 1 |
92 | agar-plate-dilution | 1 |
93 | epha4-lyn | 1 |
94 | elgp | 4 |
95 | anti-cramp | 1 |
96 | bpmp | 6 |
97 | thumbs-up | 1 |
98 | x-omics | 2 |
99 | grievances | 2 |
100 | hplc-pad-ms | 1 |
101 | hplc/dad/esi/ms | 1 |
102 | hplc/dad/esi-ms/ms | 1 |
103 | counterplans | 3 |
104 | pre-aus | 1 |
105 | nonparticulant | 1 |
106 | akt-resistant | 1 |
107 | ampkα2-dependent | 1 |
108 | eeg-dependent | 1 |
109 | no/cgmp/pkg-dependent | 1 |
110 | nf-κb-independent | 1 |
111 | er-independent | 2 |
112 | ifnγ-independent | 1 |
113 | bioagent | 2 |
114 | ecient | 1 |
115 | addition-rearrangement | 1 |
116 | acw-treatment | 1 |
117 | ultrasound-first | 2 |
118 | catalyst/co-catalyst | 1 |
119 | tdf+ftc+zdv | 1 |
120 | anti-chikv | 1 |
121 | enrichment-window | 2 |
122 | time-delay | 9 |
123 | anthroposophy | 1 |
124 | epidural-only | 1 |
125 | alternative/complementary | 6 |
126 | open-entry | 2 |